NCT03299062 Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders Status COMPLETED Phase NA
NCT03295786 Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT03127514 AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT03065192 Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease Status COMPLETED Phase PHASE1
NCT02696603 Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower) Status ACTIVE_NOT_RECRUITING Phase NA
NCT02656498 [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease Status COMPLETED Phase PHASE2
NCT02270489 Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA Status COMPLETED Phase PHASE1
NCT02267434 Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease Status COMPLETED Phase PHASE1
NCT02106065 VA Cultivating Access to Resources, Education, and Skills for Dementia Caregivers Status COMPLETED Phase NA
NCT01954875 Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases Status WITHDRAWN Phase N/A
NCT01953523 Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions Status COMPLETED Phase NA
NCT01696591 The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD Status UNKNOWN Phase N/A
NCT01662414 Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease Status COMPLETED Phase PHASE4
NCT01550549 Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans Status COMPLETED Phase NA